chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Diuretic therapy, Dyspnoea, Echocardiogram, Ejection fraction, Fibrin D dimer
Clinical narrative: Discharge Provider: DO Primary Care Provider: MD Admission Date: 4/17/2023 Discharge Date: Apr 22, 2023   PRESENTING PROBLEM: Acute respiratory failure with hypoxia (HCC) [J96.01] Acute congestive heart failure, unspecified heart failure type (HCC) [I50.9] AKI (acute kidney injury) (HCC) [N17.9]   HOSPITAL COURSE: Patient is a 67 y.o. who presented to ED via EMS for shortness of breath.  Upon arrival to the ED, He required 2L nasal cannula after sats dropped down to 87% on room air. Significant lab work included mild hyponatremia of 133 and glucose of 138. Procal was WNL at 0.07 and proBNP was 119. D-dimer was mildly elevated at 530. Viral PCR was negative. Chest X-ray showed mild cardiomegaly and pulmonary vascular congestion without acute cardiopulmonary pathology. While in the ED patient received a 1x dose of IV lasix 40 mg.   Patient was admitted to internal medicine service for further workup and treatment of acute hypoxic respiratory failure.  Patient did become hypotensive with acute kidney injury with diuretic therapy.  He underwent an echocardiogram which showed preserved ejection fraction.  He had normal NT proBNP arguing against CHF.  He underwent a CT of the thorax which revealed a multifocal pneumonia.  Viral testing revealed COVID-19 as well as metapneumovirus.  Given his low blood pressures he was also covered empirically for bacterial pneumonia.  Patient was started on 6 mg of dexamethasone and albuterol for wheezing.  He will complete 5 days of Augmentin and azithromycin to cover community-acquired pneumonia.  He clinically improved and was weaned off of oxygen.   Patient underwent a swallow evaluation he was found have significant esophageal dysmotility.  He is tolerating diet and will follow-up with Gastroenterology as an outpatient as well as undergo a video swallow as an outpatient speech-language therapy.   He did exhibit desaturations at night, with sleep apnea suspected, outpatient sleep study recommended, he will discharge on supplemental oxygen to wear at night only.   In regards to his hypertension, patient had significant hypotension during hospitalization.  This has resolved, will hold metoprolol XL as well as losartan and continue hydrochlorothiazide at discharge.  Blood pressure medications can be resumed as tolerated as an outpatient.   Patient is clinically improved and is medically stable for transfer back to his adult foster care facility. He was needing 2 L O2 at night at time of discharge.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Human metapneumovirus test positive, Hyponatraemia, Hypotension, Laboratory test abnormal, Metapneumovirus infection
Clinical narrative: Discharge Provider: DO Primary Care Provider: MD Admission Date: 4/17/2023 Discharge Date: Apr 22, 2023   PRESENTING PROBLEM: Acute respiratory failure with hypoxia (HCC) [J96.01] Acute congestive heart failure, unspecified heart failure type (HCC) [I50.9] AKI (acute kidney injury) (HCC) [N17.9]   HOSPITAL COURSE: Patient is a 67 y.o. who presented to ED via EMS for shortness of breath.  Upon arrival to the ED, He required 2L nasal cannula after sats dropped down to 87% on room air. Significant lab work included mild hyponatremia of 133 and glucose of 138. Procal was WNL at 0.07 and proBNP was 119. D-dimer was mildly elevated at 530. Viral PCR was negative. Chest X-ray showed mild cardiomegaly and pulmonary vascular congestion without acute cardiopulmonary pathology. While in the ED patient received a 1x dose of IV lasix 40 mg.   Patient was admitted to internal medicine service for further workup and treatment of acute hypoxic respiratory failure.  Patient did become hypotensive with acute kidney injury with diuretic therapy.  He underwent an echocardiogram which showed preserved ejection fraction.  He had normal NT proBNP arguing against CHF.  He underwent a CT of the thorax which revealed a multifocal pneumonia.  Viral testing revealed COVID-19 as well as metapneumovirus.  Given his low blood pressures he was also covered empirically for bacterial pneumonia.  Patient was started on 6 mg of dexamethasone and albuterol for wheezing.  He will complete 5 days of Augmentin and azithromycin to cover community-acquired pneumonia.  He clinically improved and was weaned off of oxygen.   Patient underwent a swallow evaluation he was found have significant esophageal dysmotility.  He is tolerating diet and will follow-up with Gastroenterology as an outpatient as well as undergo a video swallow as an outpatient speech-language therapy.   He did exhibit desaturations at night, with sleep apnea suspected, outpatient sleep study recommended, he will discharge on supplemental oxygen to wear at night only.   In regards to his hypertension, patient had significant hypotension during hospitalization.  This has resolved, will hold metoprolol XL as well as losartan and continue hydrochlorothiazide at discharge.  Blood pressure medications can be resumed as tolerated as an outpatient.   Patient is clinically improved and is medically stable for transfer back to his adult foster care facility. He was needing 2 L O2 at night at time of discharge.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Oesophageal motility disorder, Oxygen saturation decreased, Pneumonia, Pneumonia bacterial, Procalcitonin
Clinical narrative: Discharge Provider: DO Primary Care Provider: MD Admission Date: 4/17/2023 Discharge Date: Apr 22, 2023   PRESENTING PROBLEM: Acute respiratory failure with hypoxia (HCC) [J96.01] Acute congestive heart failure, unspecified heart failure type (HCC) [I50.9] AKI (acute kidney injury) (HCC) [N17.9]   HOSPITAL COURSE: Patient is a 67 y.o. who presented to ED via EMS for shortness of breath.  Upon arrival to the ED, He required 2L nasal cannula after sats dropped down to 87% on room air. Significant lab work included mild hyponatremia of 133 and glucose of 138. Procal was WNL at 0.07 and proBNP was 119. D-dimer was mildly elevated at 530. Viral PCR was negative. Chest X-ray showed mild cardiomegaly and pulmonary vascular congestion without acute cardiopulmonary pathology. While in the ED patient received a 1x dose of IV lasix 40 mg.   Patient was admitted to internal medicine service for further workup and treatment of acute hypoxic respiratory failure.  Patient did become hypotensive with acute kidney injury with diuretic therapy.  He underwent an echocardiogram which showed preserved ejection fraction.  He had normal NT proBNP arguing against CHF.  He underwent a CT of the thorax which revealed a multifocal pneumonia.  Viral testing revealed COVID-19 as well as metapneumovirus.  Given his low blood pressures he was also covered empirically for bacterial pneumonia.  Patient was started on 6 mg of dexamethasone and albuterol for wheezing.  He will complete 5 days of Augmentin and azithromycin to cover community-acquired pneumonia.  He clinically improved and was weaned off of oxygen.   Patient underwent a swallow evaluation he was found have significant esophageal dysmotility.  He is tolerating diet and will follow-up with Gastroenterology as an outpatient as well as undergo a video swallow as an outpatient speech-language therapy.   He did exhibit desaturations at night, with sleep apnea suspected, outpatient sleep study recommended, he will discharge on supplemental oxygen to wear at night only.   In regards to his hypertension, patient had significant hypotension during hospitalization.  This has resolved, will hold metoprolol XL as well as losartan and continue hydrochlorothiazide at discharge.  Blood pressure medications can be resumed as tolerated as an outpatient.   Patient is clinically improved and is medically stable for transfer back to his adult foster care facility. He was needing 2 L O2 at night at time of discharge.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Prohormone brain natriuretic peptide increased, Pulmonary congestion, SARS-CoV-2 test positive, Sleep apnoea syndrome, Swallow study abnormal
Clinical narrative: Discharge Provider: DO Primary Care Provider: MD Admission Date: 4/17/2023 Discharge Date: Apr 22, 2023   PRESENTING PROBLEM: Acute respiratory failure with hypoxia (HCC) [J96.01] Acute congestive heart failure, unspecified heart failure type (HCC) [I50.9] AKI (acute kidney injury) (HCC) [N17.9]   HOSPITAL COURSE: Patient is a 67 y.o. who presented to ED via EMS for shortness of breath.  Upon arrival to the ED, He required 2L nasal cannula after sats dropped down to 87% on room air. Significant lab work included mild hyponatremia of 133 and glucose of 138. Procal was WNL at 0.07 and proBNP was 119. D-dimer was mildly elevated at 530. Viral PCR was negative. Chest X-ray showed mild cardiomegaly and pulmonary vascular congestion without acute cardiopulmonary pathology. While in the ED patient received a 1x dose of IV lasix 40 mg.   Patient was admitted to internal medicine service for further workup and treatment of acute hypoxic respiratory failure.  Patient did become hypotensive with acute kidney injury with diuretic therapy.  He underwent an echocardiogram which showed preserved ejection fraction.  He had normal NT proBNP arguing against CHF.  He underwent a CT of the thorax which revealed a multifocal pneumonia.  Viral testing revealed COVID-19 as well as metapneumovirus.  Given his low blood pressures he was also covered empirically for bacterial pneumonia.  Patient was started on 6 mg of dexamethasone and albuterol for wheezing.  He will complete 5 days of Augmentin and azithromycin to cover community-acquired pneumonia.  He clinically improved and was weaned off of oxygen.   Patient underwent a swallow evaluation he was found have significant esophageal dysmotility.  He is tolerating diet and will follow-up with Gastroenterology as an outpatient as well as undergo a video swallow as an outpatient speech-language therapy.   He did exhibit desaturations at night, with sleep apnea suspected, outpatient sleep study recommended, he will discharge on supplemental oxygen to wear at night only.   In regards to his hypertension, patient had significant hypotension during hospitalization.  This has resolved, will hold metoprolol XL as well as losartan and continue hydrochlorothiazide at discharge.  Blood pressure medications can be resumed as tolerated as an outpatient.   Patient is clinically improved and is medically stable for transfer back to his adult foster care facility. He was needing 2 L O2 at night at time of discharge.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Viral test positive, Wheezing
Clinical narrative: Discharge Provider: DO Primary Care Provider: MD Admission Date: 4/17/2023 Discharge Date: Apr 22, 2023   PRESENTING PROBLEM: Acute respiratory failure with hypoxia (HCC) [J96.01] Acute congestive heart failure, unspecified heart failure type (HCC) [I50.9] AKI (acute kidney injury) (HCC) [N17.9]   HOSPITAL COURSE: Patient is a 67 y.o. who presented to ED via EMS for shortness of breath.  Upon arrival to the ED, He required 2L nasal cannula after sats dropped down to 87% on room air. Significant lab work included mild hyponatremia of 133 and glucose of 138. Procal was WNL at 0.07 and proBNP was 119. D-dimer was mildly elevated at 530. Viral PCR was negative. Chest X-ray showed mild cardiomegaly and pulmonary vascular congestion without acute cardiopulmonary pathology. While in the ED patient received a 1x dose of IV lasix 40 mg.   Patient was admitted to internal medicine service for further workup and treatment of acute hypoxic respiratory failure.  Patient did become hypotensive with acute kidney injury with diuretic therapy.  He underwent an echocardiogram which showed preserved ejection fraction.  He had normal NT proBNP arguing against CHF.  He underwent a CT of the thorax which revealed a multifocal pneumonia.  Viral testing revealed COVID-19 as well as metapneumovirus.  Given his low blood pressures he was also covered empirically for bacterial pneumonia.  Patient was started on 6 mg of dexamethasone and albuterol for wheezing.  He will complete 5 days of Augmentin and azithromycin to cover community-acquired pneumonia.  He clinically improved and was weaned off of oxygen.   Patient underwent a swallow evaluation he was found have significant esophageal dysmotility.  He is tolerating diet and will follow-up with Gastroenterology as an outpatient as well as undergo a video swallow as an outpatient speech-language therapy.   He did exhibit desaturations at night, with sleep apnea suspected, outpatient sleep study recommended, he will discharge on supplemental oxygen to wear at night only.   In regards to his hypertension, patient had significant hypotension during hospitalization.  This has resolved, will hold metoprolol XL as well as losartan and continue hydrochlorothiazide at discharge.  Blood pressure medications can be resumed as tolerated as an outpatient.   Patient is clinically improved and is medically stable for transfer back to his adult foster care facility. He was needing 2 L O2 at night at time of discharge.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Hypoxia, Spondylitis
Clinical narrative: HYPOXIA 2/4/2022 ATRIAL FIBRILLATION, UNSPECIFIED  HYPOXIA 2/4/2022 SPONDYLITIS OF LUMBOSACRAL SPINE
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ear infection, Ear pain, Sinusitis
Clinical narrative: I did not have an adverse reaction to the vaccine. On 02/01/2023, my ears began to hurt. On 05/07/2023, I was diagnosed with an ear infection in both ears and I sinus infection. I am taking an antibiotic for the infections.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Hypotension, Obstructive sleep apnoea syndrome
Clinical narrative: HYPOTENSION 2/15/2021 ATRIAL FIBRILLATION, UNSPECIFIED  HYPOTENSION 2/15/2021 ADULT OBSTRUCTIVE SLEEP APNEA, MILD
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Rhinorrhoea, Throat clearing
Clinical narrative: I had my vaccination on 08/01/2022. I started to experience sore throat runny nose and cough in 12/12022. I am always having to have cough drops with me. The cough is more to having to constantly clear my throat. I have never had this issue before.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Computerised tomogram thorax, Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
Clinical narrative: had COVID after the vaccine and now has a new diagnosis of DIPNECH
Age: 54.0
Sex: F
Vaccine: COVID19-2, HEP, MMR, VARZOS
Symptoms: Asthma, Dyspnoea, Hypertension
Clinical narrative: She claims she had an asthma attack - couldn't breathe, felt that her BP was high a few hours after leaving the clinic.  She went to the Emergency Room at 10:51 pm the same day.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Obstructive sleep apnoea syndrome
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE HYPOXIA
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Autoimmune disorder, Blood test abnormal, Cold agglutinins positive, Condition aggravated, Haemolytic anaemia
Clinical narrative: One hundred fifty days after receiving the fifth vaccine I started having signs that my autoimmune disease is back. My skin on parts of my body has turned yellow. I went to my doctor, who took blood test confirm that the autoimmune disease was back. Once the blood test confirmed what both the doctor and I suspected, I started receiving the infusion treatment.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Yellow skin
Clinical narrative: One hundred fifty days after receiving the fifth vaccine I started having signs that my autoimmune disease is back. My skin on parts of my body has turned yellow. I went to my doctor, who took blood test confirm that the autoimmune disease was back. Once the blood test confirmed what both the doctor and I suspected, I started receiving the infusion treatment.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Atrial fibrillation, COVID-19, Cardiac stress test, Dizziness
Clinical narrative: I was having a lot of shortness breath and was very tired and fatigued whenever I walked. I ended up going getting tested and I was positive for COVID-19. I slept for about 14 days but after this I started having the shortness of breath and fatigue and in one instance I almost passed out and my Apple Watched indicated that I was having AFIB, and I went to the ER. They did lab work and then and an EKG, and we found I had a UTI as well. I was admitted to the hospital overnight. They increased my medication for my heart, and I had a follow up with the cardiologist two weeks later. They added a blood thinner to my medications and kept the higher dose of the medication from the ER. We ended up doing a stress test as well because of a non-related surgery I had coming up.  I have been able to manage this new condition through medication
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram abnormal, Fatigue, Hypersomnia, Laboratory test abnormal
Clinical narrative: I was having a lot of shortness breath and was very tired and fatigued whenever I walked. I ended up going getting tested and I was positive for COVID-19. I slept for about 14 days but after this I started having the shortness of breath and fatigue and in one instance I almost passed out and my Apple Watched indicated that I was having AFIB, and I went to the ER. They did lab work and then and an EKG, and we found I had a UTI as well. I was admitted to the hospital overnight. They increased my medication for my heart, and I had a follow up with the cardiologist two weeks later. They added a blood thinner to my medications and kept the higher dose of the medication from the ER. We ended up doing a stress test as well because of a non-related surgery I had coming up.  I have been able to manage this new condition through medication
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: I was having a lot of shortness breath and was very tired and fatigued whenever I walked. I ended up going getting tested and I was positive for COVID-19. I slept for about 14 days but after this I started having the shortness of breath and fatigue and in one instance I almost passed out and my Apple Watched indicated that I was having AFIB, and I went to the ER. They did lab work and then and an EKG, and we found I had a UTI as well. I was admitted to the hospital overnight. They increased my medication for my heart, and I had a follow up with the cardiologist two weeks later. They added a blood thinner to my medications and kept the higher dose of the medication from the ER. We ended up doing a stress test as well because of a non-related surgery I had coming up.  I have been able to manage this new condition through medication
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 5/20/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination error
Clinical narrative: Patient was given 2nd primary (monovalent) dose of Moderna .25 was given to after the patient was 6 years old. No known VERS experienced by patient, This was an Vaccine error. Patient first dose was given on  3-4-2023.
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Asthenia, Dizziness, Vision blurred
Clinical narrative: After receiving  TDAP, HPV, MCV4 vaccines patient began to experience dizziness, weakness, and blurry vision.  VS were obtained at 9:55AM; BP 105/70, O2 95%, HR 54.  Cold pack was applied to back of neck.  Mother stated no prior history of vaccine reactions and no allergies.  Patient showed no signs of improvement; EMS was called at 10:07AM.  Patient stated she was feeling better at 10:15AM.   EMS arrived at 10:20AM, VS retaken O2 100%, HR 90.  Patient was transferred to EMS and discharged.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 03/01/23 presents to ED for "shortness of breath". PMHx of "CLL, emphysema, COPD, s/p rectal cancer 2022"
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Pulmonary embolism, Pulmonary mass
Clinical narrative: ACUTE PULMONARY EMBOLISM 5/6/2022 LUNG MASS  HYPOXIA 4/26/2022 LUNG MASS  ACUTE PULMONARY EMBOLISM 5/6/2022 LUNG MASS  HYPOXIA 4/26/2022 LUNG MASS
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION 2/24/2023 -- RECURRENCE OF SAME SYMPTOMS
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Aortic aneurysm, Aortic aneurysm repair, Aortic dissection, Computerised tomogram thorax abnormal, Malaise
Clinical narrative: 4/6/23 I did not feel well. I was taken to the emergency room and had a CT. I was diagnosed with a 6.7-centimeter aortic aneurysm and descending dissection. I had an aneurysm repair on 4/10/23. I was in the hospital until 4/20/23. When I was discharged, I was sent home with nurses and had physical therapy. I was not started on any new medication.
Age: 94.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 03/02/23 presents to ED for "shortness of breath". PMHx of "dementia, hypothyroidism"
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Acute respiratory failure, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI ACUTE RESPIRATORY FAILURE 1/2/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Muscle injury, Myalgia, Pain, Sleep disorder
Clinical narrative: My arm at injection site became very sore.  The pain/injury seems to be in the mussel tissue.    The pain is severe when I move the arm into certain positions.  It keeps me from sleeping in my normal sleeping positions.  After 7 months, the symptoms have not changed or diminished.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Angina unstable
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE UNSTABLE ANGINA ANGINA, UNSPECIFIED
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Palpitations, SARS-CoV-2 test positive
Clinical narrative: 03/02/23 presents to ED for "palpitations, shortness of breath". PMHx of " htn, asthma, atrial firbillation on eliquis, DM, NICM EF 20%, s/p AICD"
Age: 23.0
Sex: M
Vaccine: HEP
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient had no symptoms, patient received a pediatric dose for his last Hep B series.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep apnoea syndrome
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE SLEEP APNEA
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 03/04/23 presents to ED for "shortness of breath, weakness". PMHx of "HTN, OSA"
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE
Age: 46.0
Sex: F
Vaccine: HEP
Symptoms: Underdose
Clinical narrative: Patient received a pediatric dose for first Hep B vaccine.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Lower respiratory tract infection, SARS-CoV-2 test positive, Sinus disorder, Vaccine breakthrough infection
Clinical narrative: I experienced a breakthrough case of COVID-19 with sinus and chest cold
Age: 46.0
Sex: F
Vaccine: HEP
Symptoms: Underdose
Clinical narrative: Patient received a pediatric dose for 2nd Hep B vaccine.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 03/07/23 presents to ED for "shortness of breath". PMHx of "COPD"
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Obstructive sleep apnoea syndrome, Pulmonary embolism
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Asthenia, Chills, Lip swelling, Myalgia
Clinical narrative: Patient called this morning and said she had the usual adverse reaction on 5/7/23 low grade fever, weakness, chill, muscle ache and joint ache., then on 5/8/23 she woke up with swollen lips and edge of her nose.  She said it didn't get worse or swollen tongue or throat.  She felt normal otherwise. We helped pt to call PCP  and pt also got an appt with md right away to be evaluated.  Patient said she didn't have any of these reaction with the first Shingrix dose.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Nasal congestion, Pyrexia
Clinical narrative: Patient called this morning and said she had the usual adverse reaction on 5/7/23 low grade fever, weakness, chill, muscle ache and joint ache., then on 5/8/23 she woke up with swollen lips and edge of her nose.  She said it didn't get worse or swollen tongue or throat.  She felt normal otherwise. We helped pt to call PCP  and pt also got an appt with md right away to be evaluated.  Patient said she didn't have any of these reaction with the first Shingrix dose.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood copper, Blood folate, Blood iron decreased, Blood zinc
Clinical narrative: Discharge Provider: , MD Primary Care Provider: , MD Admission Date: 4/19/2023 Discharge Date: Apr 26, 2023   PRESENTING PROBLEM: Generalized weakness COVID-19    HOSPITAL COURSE: Patient is an 91 y/o male with past medical history of anemia, hypertension, and BPH who presented to the emergency department with generalized weakness.  In the emergency department he was afebrile. Chest x-ray showed mild pulmonary venous congestion.  COVID PCR was positive.  He was admitted to the hospitalist service.     He remained asymptomatic from a COVID perspective and did not require further treatment. He had iron studies checked for microcytic anemia and iron deficiency was found.  The patient completed IV iron. Hematology was consulted d/t worsening pancytopenia. It was suspected pancytopenia was likely r/t COVID infection. Nutritional and vitamin deficiencies were evaluated with reassuring B12 and folate levels. Copper and Zinc were collected and pending at time of discharge.   PT/OT evaluated the patient and initially recommended acute rehab at discharge.  PMR was consulted who felt he would be most appropriate for subacute rehab versus progress to home pending functional progress with therapies.  Patient continued to work with therapy while awaiting SAR and he did improve to discharge home with services.     Patient will need follow up with pcp post hospitalization along with repeat cbc in 4-6 weeks, if no improvement in pancytopenia would benefit from outpatient hematology referral. Zinc and Copper levels pending at discharge, if found to be low would benefit from supplementation given this may be contributing to anemia.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Full blood count abnormal, Iron deficiency, Pancytopenia
Clinical narrative: Discharge Provider: , MD Primary Care Provider: , MD Admission Date: 4/19/2023 Discharge Date: Apr 26, 2023   PRESENTING PROBLEM: Generalized weakness COVID-19    HOSPITAL COURSE: Patient is an 91 y/o male with past medical history of anemia, hypertension, and BPH who presented to the emergency department with generalized weakness.  In the emergency department he was afebrile. Chest x-ray showed mild pulmonary venous congestion.  COVID PCR was positive.  He was admitted to the hospitalist service.     He remained asymptomatic from a COVID perspective and did not require further treatment. He had iron studies checked for microcytic anemia and iron deficiency was found.  The patient completed IV iron. Hematology was consulted d/t worsening pancytopenia. It was suspected pancytopenia was likely r/t COVID infection. Nutritional and vitamin deficiencies were evaluated with reassuring B12 and folate levels. Copper and Zinc were collected and pending at time of discharge.   PT/OT evaluated the patient and initially recommended acute rehab at discharge.  PMR was consulted who felt he would be most appropriate for subacute rehab versus progress to home pending functional progress with therapies.  Patient continued to work with therapy while awaiting SAR and he did improve to discharge home with services.     Patient will need follow up with pcp post hospitalization along with repeat cbc in 4-6 weeks, if no improvement in pancytopenia would benefit from outpatient hematology referral. Zinc and Copper levels pending at discharge, if found to be low would benefit from supplementation given this may be contributing to anemia.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary congestion, SARS-CoV-2 test positive, Vitamin B12
Clinical narrative: Discharge Provider: , MD Primary Care Provider: , MD Admission Date: 4/19/2023 Discharge Date: Apr 26, 2023   PRESENTING PROBLEM: Generalized weakness COVID-19    HOSPITAL COURSE: Patient is an 91 y/o male with past medical history of anemia, hypertension, and BPH who presented to the emergency department with generalized weakness.  In the emergency department he was afebrile. Chest x-ray showed mild pulmonary venous congestion.  COVID PCR was positive.  He was admitted to the hospitalist service.     He remained asymptomatic from a COVID perspective and did not require further treatment. He had iron studies checked for microcytic anemia and iron deficiency was found.  The patient completed IV iron. Hematology was consulted d/t worsening pancytopenia. It was suspected pancytopenia was likely r/t COVID infection. Nutritional and vitamin deficiencies were evaluated with reassuring B12 and folate levels. Copper and Zinc were collected and pending at time of discharge.   PT/OT evaluated the patient and initially recommended acute rehab at discharge.  PMR was consulted who felt he would be most appropriate for subacute rehab versus progress to home pending functional progress with therapies.  Patient continued to work with therapy while awaiting SAR and he did improve to discharge home with services.     Patient will need follow up with pcp post hospitalization along with repeat cbc in 4-6 weeks, if no improvement in pancytopenia would benefit from outpatient hematology referral. Zinc and Copper levels pending at discharge, if found to be low would benefit from supplementation given this may be contributing to anemia.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Malaise, Pneumonia, Respiratory tract congestion, Rib fracture
Clinical narrative: I had a congestion that became pneumonia, I cracked my rib because I was cough so hard. I don't remember being this sick in my whole life, I still have a lot of congestion that its not going away. I very troubled by it, I wouldn't think it had to do with the vaccine but I am not sure.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/15/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arteriovenous malformation, COVID-19, Chills, Culture negative, Decreased appetite
Clinical narrative: Discharge Provider: DO Primary Care Provider: MD Admission Date: 4/20/2023 Discharge Date: 04/28/2023 Presenting Problem: Fever and chills  HOSPITAL COURSE: No notes on file The patient is a 73 year old male with PMH of OHT 6/15/2020, ESRD on PD, OSA, dyslipidemia who presented on 4/20/23 from dialysis where he was found to be hypotensive, febrile and fatigued.  Patient was diagnosed with COVID at the end of March and with concurrent bacterial PNA, prompting holding of MMF (4/5/23).     On arrival, he was noted to be dehydrated and hypotensive, stating he has felt miserable for the past week with poor appetite/oral intake and severe fatigue.  He was also found to be COVID positive on 4/20/23. Other cultures and infectious studies were unremarkable. He was treated with remdesivir per ID recommendations.  An echo demonstrated preserved biventricular function.  His hospitalization was complicated by an acute GI bleed.  On 4/25, he underwent EGD/sigmoidoscopy demonstrating AVMs which were treated.  Nephrology was also consulted for dialysis management.  Patient then continued to improve with electrolyte repletion, fluid management, and 2units PRBC transfusion.  On 4/27, patient was stable and feeling improved, without indications to stay inpatient.  He expressed significant desire to return home.  Plan was discussed including follow up and changes to medications.  Patient and spouse verbalized understanding.  Questions answered.  He was discharged in stable condition.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dehydration, Echocardiogram abnormal, Electrolyte substitution therapy, Fatigue, Feeling abnormal
Clinical narrative: Discharge Provider: DO Primary Care Provider: MD Admission Date: 4/20/2023 Discharge Date: 04/28/2023 Presenting Problem: Fever and chills  HOSPITAL COURSE: No notes on file The patient is a 73 year old male with PMH of OHT 6/15/2020, ESRD on PD, OSA, dyslipidemia who presented on 4/20/23 from dialysis where he was found to be hypotensive, febrile and fatigued.  Patient was diagnosed with COVID at the end of March and with concurrent bacterial PNA, prompting holding of MMF (4/5/23).     On arrival, he was noted to be dehydrated and hypotensive, stating he has felt miserable for the past week with poor appetite/oral intake and severe fatigue.  He was also found to be COVID positive on 4/20/23. Other cultures and infectious studies were unremarkable. He was treated with remdesivir per ID recommendations.  An echo demonstrated preserved biventricular function.  His hospitalization was complicated by an acute GI bleed.  On 4/25, he underwent EGD/sigmoidoscopy demonstrating AVMs which were treated.  Nephrology was also consulted for dialysis management.  Patient then continued to improve with electrolyte repletion, fluid management, and 2units PRBC transfusion.  On 4/27, patient was stable and feeling improved, without indications to stay inpatient.  He expressed significant desire to return home.  Plan was discussed including follow up and changes to medications.  Patient and spouse verbalized understanding.  Questions answered.  He was discharged in stable condition.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Gastrointestinal haemorrhage, Hypophagia, Hypotension, Laboratory test normal, Oesophagogastroduodenoscopy abnormal
Clinical narrative: Discharge Provider: DO Primary Care Provider: MD Admission Date: 4/20/2023 Discharge Date: 04/28/2023 Presenting Problem: Fever and chills  HOSPITAL COURSE: No notes on file The patient is a 73 year old male with PMH of OHT 6/15/2020, ESRD on PD, OSA, dyslipidemia who presented on 4/20/23 from dialysis where he was found to be hypotensive, febrile and fatigued.  Patient was diagnosed with COVID at the end of March and with concurrent bacterial PNA, prompting holding of MMF (4/5/23).     On arrival, he was noted to be dehydrated and hypotensive, stating he has felt miserable for the past week with poor appetite/oral intake and severe fatigue.  He was also found to be COVID positive on 4/20/23. Other cultures and infectious studies were unremarkable. He was treated with remdesivir per ID recommendations.  An echo demonstrated preserved biventricular function.  His hospitalization was complicated by an acute GI bleed.  On 4/25, he underwent EGD/sigmoidoscopy demonstrating AVMs which were treated.  Nephrology was also consulted for dialysis management.  Patient then continued to improve with electrolyte repletion, fluid management, and 2units PRBC transfusion.  On 4/27, patient was stable and feeling improved, without indications to stay inpatient.  He expressed significant desire to return home.  Plan was discussed including follow up and changes to medications.  Patient and spouse verbalized understanding.  Questions answered.  He was discharged in stable condition.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pneumonia bacterial, Pyrexia, Red blood cell transfusion, SARS-CoV-2 test positive, Sigmoidoscopy abnormal
Clinical narrative: Discharge Provider: DO Primary Care Provider: MD Admission Date: 4/20/2023 Discharge Date: 04/28/2023 Presenting Problem: Fever and chills  HOSPITAL COURSE: No notes on file The patient is a 73 year old male with PMH of OHT 6/15/2020, ESRD on PD, OSA, dyslipidemia who presented on 4/20/23 from dialysis where he was found to be hypotensive, febrile and fatigued.  Patient was diagnosed with COVID at the end of March and with concurrent bacterial PNA, prompting holding of MMF (4/5/23).     On arrival, he was noted to be dehydrated and hypotensive, stating he has felt miserable for the past week with poor appetite/oral intake and severe fatigue.  He was also found to be COVID positive on 4/20/23. Other cultures and infectious studies were unremarkable. He was treated with remdesivir per ID recommendations.  An echo demonstrated preserved biventricular function.  His hospitalization was complicated by an acute GI bleed.  On 4/25, he underwent EGD/sigmoidoscopy demonstrating AVMs which were treated.  Nephrology was also consulted for dialysis management.  Patient then continued to improve with electrolyte repletion, fluid management, and 2units PRBC transfusion.  On 4/27, patient was stable and feeling improved, without indications to stay inpatient.  He expressed significant desire to return home.  Plan was discussed including follow up and changes to medications.  Patient and spouse verbalized understanding.  Questions answered.  He was discharged in stable condition.
Age: 94.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Malaise, Nausea, SARS-CoV-2 test positive
Clinical narrative: 03/08/23 presents to EC ED for "nausea, vomiting, malaise, fatigue". PMHx of "HTN, atrial fibrillation, CKD, CHF"
Age: 94.0
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: 03/08/23 presents to EC ED for "nausea, vomiting, malaise, fatigue". PMHx of "HTN, atrial fibrillation, CKD, CHF"
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 4/1/2023 - 4/4/2023 (3 days) Presentation to the ED: SOB.  COVID + date: 4/1/2023 Treatment: remdesivir, steroids,    Discharge to: home.   013L20A 1/19/2021 031L20A 2/16/2021 041J21A 12/17/2021
Age: 55.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Blood test abnormal, COVID-19, Computerised tomogram thorax abnormal, Cough, Headache
Clinical narrative: I had a fever, coughing, headache, achy all over, my sense of taste changed, I used a home COVID-19 test that came back positive. I was going to let the virus run it's course. Then I started to feel extremely horrible, so I went to the emergency room. They tested me for COVID-19, it came back negative, they could hear rattling in my chest, a CT scan was ordered as well as bloodwork. The CT scan found that I had pneumonia, the bloodwork revealed I also had sepsis. I was admitted to the hospital where I spent five days to recover.
Age: 55.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Malaise, Pain, Pneumonia, Pyrexia, Rales
Clinical narrative: I had a fever, coughing, headache, achy all over, my sense of taste changed, I used a home COVID-19 test that came back positive. I was going to let the virus run it's course. Then I started to feel extremely horrible, so I went to the emergency room. They tested me for COVID-19, it came back negative, they could hear rattling in my chest, a CT scan was ordered as well as bloodwork. The CT scan found that I had pneumonia, the bloodwork revealed I also had sepsis. I was admitted to the hospital where I spent five days to recover.
Age: 55.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: SARS-CoV-2 test positive, Sepsis, Taste disorder
Clinical narrative: I had a fever, coughing, headache, achy all over, my sense of taste changed, I used a home COVID-19 test that came back positive. I was going to let the virus run it's course. Then I started to feel extremely horrible, so I went to the emergency room. They tested me for COVID-19, it came back negative, they could hear rattling in my chest, a CT scan was ordered as well as bloodwork. The CT scan found that I had pneumonia, the bloodwork revealed I also had sepsis. I was admitted to the hospital where I spent five days to recover.
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Herpes zoster, Injection site erythema, Pain in extremity
Clinical narrative: I had a sore arm with some redness at the injection site for about a day. I also felt very tired too. I developed Shingles on 04/18/2023. I was a seven-day course of antibiotics. I am still healing but I do feel better.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 4/1/2023 - 4/9/2023 (8 days) Presentation to the ED: fall.  COVID + date: 4/1/2023 Treatment: IV Remdesivir & on IV Decadron x 10 days Discharge to: SNF.   021B21A 4/2/2021  009C21A 4/30/2021 049L21A 5/13/2022
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood iron decreased, COVID-19, Cardiac failure congestive, Cardiac output decreased, Cardiogenic shock
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 4/24/2023 Discharge Date: 04/25/2023 Presenting Problem: CHF (congestive heart failure)  CHF (congestive heart failure)   HOSPITAL COURSE: 70 year old pt. Of Dr. with past medical history of CAD with anterior MI in 2013, ICM EF 22% s/p ICD, hypertension, hyperlipidemia, obesity. Patient reported ongoing dyspnea on exertion, arranged for outpatient R/LHC that showed elevated filling pressures and cardiogenic shock.    Patient was admitted to AHF service and placed on RDT. RHC 4/24 showed RA 11, PA 54/28/37, W 33, FCI 1.6 (wt 110.9 kg). LHC showed MVCAD (100% occluded mid LAD, known occluded prox RCA not imaged). His CAD was unchanged compared to prior angiogram in 2013, continue medical management; ASA, statin, and BB.    Of note, on admit, patient tested positive for COVID. He was asymptomatic, stable on RA, supportive care continued. He had COVID in December, this is when all his symptoms started, COVID+ this admit may be from December infection.    Iron studies on admit consistent with iron deficiency anemia (ferritin 60). Given quick discharge timing, he did not receive any IV iron, IV ferrlecit was ordered 4/25 but patient refused, he did not receive any IV iron inpatient. Also with quick discharge he would have only received one dose of IV iron, evaluate outpatient for IV iron.     GDMT; given low cardiac output (FCI of 1.6), coreg dose was reduced. Entresto was increased. Added spiro. Dr. triggered patient for outpatient LVAD evaluation.    This patient was on the Diuresis Team and was stable but remained hypervolemic at time of discharge.  Patient was diuresed with IV lasix (40mg x1 and 80mg x1) then transitioned to torsemide 60mg daily.   Estimated dry weight is <107 kg. Weight on discharge is 107.8 kg. Consider patient for Cardiomems implant
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Catheterisation cardiac abnormal, Condition aggravated, Coronary artery disease, Coronary artery occlusion, Diuretic therapy
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 4/24/2023 Discharge Date: 04/25/2023 Presenting Problem: CHF (congestive heart failure)  CHF (congestive heart failure)   HOSPITAL COURSE: 70 year old pt. Of Dr. with past medical history of CAD with anterior MI in 2013, ICM EF 22% s/p ICD, hypertension, hyperlipidemia, obesity. Patient reported ongoing dyspnea on exertion, arranged for outpatient R/LHC that showed elevated filling pressures and cardiogenic shock.    Patient was admitted to AHF service and placed on RDT. RHC 4/24 showed RA 11, PA 54/28/37, W 33, FCI 1.6 (wt 110.9 kg). LHC showed MVCAD (100% occluded mid LAD, known occluded prox RCA not imaged). His CAD was unchanged compared to prior angiogram in 2013, continue medical management; ASA, statin, and BB.    Of note, on admit, patient tested positive for COVID. He was asymptomatic, stable on RA, supportive care continued. He had COVID in December, this is when all his symptoms started, COVID+ this admit may be from December infection.    Iron studies on admit consistent with iron deficiency anemia (ferritin 60). Given quick discharge timing, he did not receive any IV iron, IV ferrlecit was ordered 4/25 but patient refused, he did not receive any IV iron inpatient. Also with quick discharge he would have only received one dose of IV iron, evaluate outpatient for IV iron.     GDMT; given low cardiac output (FCI of 1.6), coreg dose was reduced. Entresto was increased. Added spiro. Dr. triggered patient for outpatient LVAD evaluation.    This patient was on the Diuresis Team and was stable but remained hypervolemic at time of discharge.  Patient was diuresed with IV lasix (40mg x1 and 80mg x1) then transitioned to torsemide 60mg daily.   Estimated dry weight is <107 kg. Weight on discharge is 107.8 kg. Consider patient for Cardiomems implant
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dyspnoea exertional, Hypervolaemia, Iron deficiency anaemia, Left ventricular end-diastolic pressure increased, Mitral valve disease
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 4/24/2023 Discharge Date: 04/25/2023 Presenting Problem: CHF (congestive heart failure)  CHF (congestive heart failure)   HOSPITAL COURSE: 70 year old pt. Of Dr. with past medical history of CAD with anterior MI in 2013, ICM EF 22% s/p ICD, hypertension, hyperlipidemia, obesity. Patient reported ongoing dyspnea on exertion, arranged for outpatient R/LHC that showed elevated filling pressures and cardiogenic shock.    Patient was admitted to AHF service and placed on RDT. RHC 4/24 showed RA 11, PA 54/28/37, W 33, FCI 1.6 (wt 110.9 kg). LHC showed MVCAD (100% occluded mid LAD, known occluded prox RCA not imaged). His CAD was unchanged compared to prior angiogram in 2013, continue medical management; ASA, statin, and BB.    Of note, on admit, patient tested positive for COVID. He was asymptomatic, stable on RA, supportive care continued. He had COVID in December, this is when all his symptoms started, COVID+ this admit may be from December infection.    Iron studies on admit consistent with iron deficiency anemia (ferritin 60). Given quick discharge timing, he did not receive any IV iron, IV ferrlecit was ordered 4/25 but patient refused, he did not receive any IV iron inpatient. Also with quick discharge he would have only received one dose of IV iron, evaluate outpatient for IV iron.     GDMT; given low cardiac output (FCI of 1.6), coreg dose was reduced. Entresto was increased. Added spiro. Dr. triggered patient for outpatient LVAD evaluation.    This patient was on the Diuresis Team and was stable but remained hypervolemic at time of discharge.  Patient was diuresed with IV lasix (40mg x1 and 80mg x1) then transitioned to torsemide 60mg daily.   Estimated dry weight is <107 kg. Weight on discharge is 107.8 kg. Consider patient for Cardiomems implant